108 related articles for article (PubMed ID: 8026064)
1. Azathioprine vs cyclosporine in recipients of HLA-identical renal allografts.
Gill IS; Hodge EE; Novick AC; Streem SB; Braun WE; Paranandi L
Cleve Clin J Med; 1994; 61(3):206-10. PubMed ID: 8026064
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
[TBL] [Abstract][Full Text] [Related]
3. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
[TBL] [Abstract][Full Text] [Related]
4. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
Sumrani N; Delaney V; Ding ZK; Butt K; Hong J
Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quadruple immunosuppression with cyclosporine induction therapy in high risk renal transplant recipients.
Indudhara R; Khauli RB; Menon M; Stoff JS
J Urol; 1994 Aug; 152(2 Pt 1):307-11. PubMed ID: 8015058
[TBL] [Abstract][Full Text] [Related]
6. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
[No Abstract] [Full Text] [Related]
7. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
8. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
10. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation.
Lindholm A; Albrechtsen D; Tufveson G; Karlberg I; Persson NH; Groth CG
Transplantation; 1992 Oct; 54(4):624-31. PubMed ID: 1412754
[TBL] [Abstract][Full Text] [Related]
12. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H
Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
[No Abstract] [Full Text] [Related]
13. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
14. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
Leone MR; Alexander SR; Melvin T; Striegel J; Reller K; Norman DJ; Barry JM
J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
[TBL] [Abstract][Full Text] [Related]
15. Control of cytomegalovirus disease in renal transplant patients treated with prednisone, azathioprine and cyclosporine using intensive monitoring and decreased immunosuppression.
Gómez E; de Oña M; Mélon S; Alvarez R; Laures A; Rodríguez M; Pobes A; Alvarez-Grande J
Nephron; 1999; 82(3):238-45. PubMed ID: 10395996
[TBL] [Abstract][Full Text] [Related]
16. Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus.
Ichikawa Y; Kishikawa H; Nishimura K; Tokugawa S; Yoshioka I; Arichi N; Fujii N; Kyo M; Nishikawa M
Transplant Proc; 2006 Dec; 38(10):3451-3. PubMed ID: 17175300
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
18. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
[TBL] [Abstract][Full Text] [Related]
19. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
Opelz G
Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine versus azathioprine: a 5-year followup of 200 consecutive cadaver renal transplant recipients.
Slaton JW; Kropp KA; Jhunjhunwala JS; Selman SH
J Urol; 1994 Mar; 151(3):582-5. PubMed ID: 8308962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]